Clinical Trials Logo

Sarcopenia clinical trials

View clinical trials related to Sarcopenia.

Filter by:

NCT ID: NCT04828200 Completed - Osteoarthritis Clinical Trials

The Presence Of Sarcopenia In Patients With Knee Osteoarthritis

Start date: April 10, 2016
Phase:
Study type: Observational

Osteoarthritis (OA) is one of the most common joint disorders worldwide . The knee is the most common symptomatic joint in osteoarthritis. In this study, we evaluated the presence of sarcopenia multidimensionally in patients with knee osteoarthritis (OA) using clinical, ultrasonographic and biochemical parameters, and in this respect, it was aimed to investigate the relation between OA and sarcopenia and to identify the most practical, easily accessible and inexpensive method for investigating sarcopenia.

NCT ID: NCT04796064 Completed - Sarcopenia Clinical Trials

Low Versus High-Intensity Aerobic Training in Community-dwelling Older Men With Post-COVID 19 (SARS-CoV-2) Sarcopenia

Start date: March 30, 2020
Phase: N/A
Study type: Interventional

Sarcopenia is the major health concern and common consequence of COVID-19 in the ageing population. The objective of this study is to find and compare low and high-intensity aerobic training protocols on clinical and psychological effects in community-dwelling older men with post-COVID 19 Sarcopenia.

NCT ID: NCT04777279 Completed - Sarcopenia Clinical Trials

Physical Exercise, Nutrition Supplement and Frailty of Older Population

Start date: December 9, 2020
Phase: N/A
Study type: Interventional

This study is aimed to explore the effect of physical exercise and nutrition supplement on improving frailty, depressive symptoms, and quality of life in community-dwelling older population.

NCT ID: NCT04772586 Completed - Sarcopenia Clinical Trials

Sarcopenia and Mechanical Ventilation in Older Patients Admitted Due to COVID-19

SARCO-V
Start date: September 1, 2020
Phase:
Study type: Observational

The SarcoV study aims at assessing the association between sarcopenia and the indication of mechanical ventilation in older hospitalized patients due to COVID-19 infection

NCT ID: NCT04772040 Completed - Aging Clinical Trials

Impact of Fish Oil Dose on Tissue Content and Function

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

In this 5-month study, we will track the incorporation and washout of n-3 PUFA into different tissues following two different dosing strategies in healthy young and older volunteers. All groups will be followed for washout. Data gathered from this study will be used to establish novel dosing strategies and provide insights into the incorporation of n-3 PUFAs in different tissues and their washout in young and older participants.

NCT ID: NCT04760392 Completed - Sarcopenia Clinical Trials

Goal-directed Mobilization of Medical Inpatients

GoMob-in
Start date: September 13, 2021
Phase: N/A
Study type: Interventional

Immobilization in general internal medicine inpatients is a major contributor to morbidity and mortality. Goal-directed mobilization (GDM) may improve mobility. The aim of this study is to assess, if GDM increases physical activity (DEMMI score) during hospitalization and improves quality of care until 3 months after hospitalization.

NCT ID: NCT04757454 Completed - Sarcopenia Clinical Trials

Performance Indicators of the SARC-F Questionnaire in Acute Care

SARC-F-CHUB
Start date: September 1, 2019
Phase:
Study type: Observational

The study applies the Sluggishness, Assistance in walking, Rising from a chair, Climb stairs, Falls (SARC-F) questionnaire in older patients hospitalized in an acute care geriatric unit and aims to determine its performance indicators to screen for sarcopenia according to the revised European Consensus on definition and diagnosis (EWGSOP2) within this population

NCT ID: NCT04729738 Completed - Colon Cancer Clinical Trials

The Patient in Laparoscopic Colon Surgery:Impact of Comorbidities,Frailty,Malnutrition and Sarcopenia on Short-term Mortality

Start date: June 1, 2012
Phase:
Study type: Observational

There are many factors involved in outlining the patient's profile and in defining which factors can be configured as risks related to the surgical act; for the modern surgeon it is no longer possible to identify the patient at risk of complications based on the mere age or some comorbidities historically considered more influential on the surgical outcome, but each patient must be evaluated in its entirety including age, fragility, comorbidity, state nutritional and sarcopenia and, if necessary, implementing preoperative therapeutic strategies aimed at minimizing the impact of some of these factors on the outcome of surgery. Our study aimed at creating, if possible, an "identikit" of the patient who is more likely to have serious postoperative complications; in order to improve the therapeutic decision and the approach to patients with severe surgical risk since choosing the right treatment for the right patient is essential to obtain a good result.

NCT ID: NCT04714203 Completed - Metastatic Cancer Clinical Trials

Assessment of the Prevalence of Sarcopenia in Early Palliative Cancer Patients

SPACE
Start date: June 1, 2019
Phase:
Study type: Observational

Cancer is one of the leading causes of death in the world after cardiovascular disease (8.7 million deaths in 2015 for 17.5 million cases) 1. Despite a great deal of progress in disease detection and treatment, the incidence of cancer is steadily increasing (+ 33% in 2015) and particularly in certain locations (pancreas, lungs, brain and stomach), including risk factors are not always identified. Advanced stage cancer (= metastatic) is most often incurable with the exception of germ cell tumors. Palliative care is then most often offered. Palliative care favors the patient's quality of life as a whole (medical, physical, psychological and social). The symptoms most often reported by patients are: pain, fatigue, decreased appetite, nausea, and are directly related to phenomena such as cachexia, loss of autonomy and deterioration of psychological state, resulting in decreased overall survival. Chemotherapies and targeted therapies (immunotherapy, hormonal therapy, participation in a clinical trial) can provide a benefit in quality of life and survival only in the early phase (little benefit in the terminal phase). Other prognostic factors can impact the quality of life and overall survival in these situations: sarcopenia and disorders of nutritional status (obesity, undernutrition). The study of sarcopenia by CT scan of patients in a palliative situation is still too scarce. Sarcopenia is an often underestimated event and is associated with older age, co-morbidities, increased infectious complications, and early mortality. The study of the prevalence of sarcopenia by CT scan would confirm its prognostic impact in a palliative situation.

NCT ID: NCT04707963 Completed - Sarcopenia Clinical Trials

Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Young Adults

Start date: February 6, 2021
Phase: N/A
Study type: Interventional

This study will evaluate the adaptations in skeletal muscle that occur in response to 10 weeks of weight training with or without peanut protein supplementation in untrained men and women ages 18-30